Back to Search
Start Over
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
- Source :
-
The Journal of investigative dermatology [J Invest Dermatol] 2010 Jan; Vol. 130 (1), pp. 314-6. - Publication Year :
- 2010
- Subjects :
- Benzamides
Drug Resistance, Neoplasm genetics
Female
Humans
Imatinib Mesylate
Melanoma genetics
Middle Aged
Point Mutation
Skin Neoplasms genetics
Antineoplastic Agents therapeutic use
Melanoma drug therapy
Piperazines therapeutic use
Proto-Oncogene Proteins c-kit genetics
Pyrimidines therapeutic use
Skin Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1523-1747
- Volume :
- 130
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Journal of investigative dermatology
- Publication Type :
- Report
- Accession number :
- 19812602
- Full Text :
- https://doi.org/10.1038/jid.2009.197